Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain

Autor: María-Eva Mingot-Castellano, Carlos Grande-García, David Valcárcel-Ferreiras, Clara Conill-Cortés, Loreto de Olivar-Oliver

Publikováno v: Case Reports in Hematology, Vol 2017 (2017)

Romiplostim, a thrombopoietin-receptor agonist (TPO-ra), is a highly effective option in primary immune thrombocytopenia (ITP), with 80–90% of patients achieving platelet responses after few weeks of treatment. The evidence showing remissions, that

Externí odkaz: https://doaj.org/article/4dddb6c22ad743c3a567ef280b6c2498

IBRORS-LCM: A SPANISH RETROSPECTIVE, OBSERVATIONAL, RETROSPECTIVE STUDY OF RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA (MCL) TREATED WITH IBRUTINIB IN ROUTINE CLINICAL PRACTICE

Autor: Sancho, Juan-Manuel, Marin, Ana, Fernandez, Silvia, Capote, Francisco-Javier, Canigral, Carolina, Carlos Grande García, Donato, Eva, Zeberio, Izaskun, Puerta, Jose-Manuel, Rivas, Alfredo, Perez-Ceballos, Elena, Vale, Ana, Jimenez, Aroa, Loriente, Cristina

Publikováno v: Haematologica
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
r-FISABIO. Repositorio Institucional de Producción Científica
Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::406f4629054b9586bcef803c392de46a
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3971

Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain

Autor: Carlos Grande-García, Clara Conill-Cortés, María-Eva Mingot-Castellano, David Valcárcel-Ferreiras, Loreto de Olivar-Oliver

Publikováno v: Case Reports in Hematology, Vol 2017 (2017)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Case Reports in Hematology

Romiplostim, a thrombopoietin-receptor agonist (TPO-ra), is a highly effective option in primary immune thrombocytopenia (ITP), with 80–90% of patients achieving platelet responses after few weeks of treatment. The evidence showing remissions, that

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::481db8faa676860dc1fbff6965856574
https://doaj.org/article/4dddb6c22ad743c3a567ef280b6c2498

[Comparison of international guidelines for primary autoimmune thrombocytopenia]

Autor: Carlos, Grande García, Rafael, Martínez Martínez, David, Valcarcel Ferreiras, Vicente, Vicente-García

Publikováno v: Medicina clinica. 143(9)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b521f0a2b8590abbd706b67d37a6900d
https://pubmed.ncbi.nlm.nih.gov/24698715

High Dose Therapy with Autologous Stem Cell Transplantation (HDT/ASCT) Support in Follicular Lymphoma (FL) a Very Long Follow-up Analysis of 640 Patients of Geltamo Spanish Group Suggests That FL Might be Cured, Even in High-Risk Patients

Autor: Carmen Marrero, S. Bobillo, Erika Coria, Teresa Palomo, Elena Perez, Javier Lopez, Isidro Jarque, Juan José Lahuerta, Lucrecia Yáñez, Maria J. Rodriguez, María Manzanares, José Javier Ferreiro, Carlos Grande García, Andrea Galeo, Laura Magnano, Antonio Salar, Ana Jiménez Ubieto, Santiago Mercadel, Carlos Vallejo, Silvana Novelli, Carmen Albo, Dolores Caballero, Reyes Arranz, Armando López-Guillermo, Luis Palomera

Publikováno v: Blood. 124:675-675

Background: Patients with high-risk FL intensified with HDT/ASCT may achieve prolonged remissions. The best timing for the procedure remains controversial. Patients who are transplanted in first response show a major Progression Free Survival (PFS) a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dbfb748ba27cd719e60b78a4326a6bc9
https://doi.org/10.1182/blood.v124.21.675.675